PBS listings to support patients with mesothelioma

From July 1, thousands of Australians and their families suffering from rare cancers and genetic disorders are set to benefit from expanded listings on the Pharmaceutical Benefits Scheme (PBS).   We are expanding the listing for Opdivo® and Yervoy® (nivolumab and ipilimumab), for the treatment of patients with unresectable malignant mesothelioma.   Unresectable malignant mesothelioma…

Details

PBS Listings to Support Patients With Mesothelioma

From July 1, thousands of Australians and their families suffering from rare cancers and genetic disorders are set to benefit from expanded listings on the Pharmaceutical Benefits Scheme (PBS).   We are expanding the listing for Opdivo® and Yervoy® (nivolumab and ipilimumab), for the treatment of patients with unresectable malignant mesothelioma.   Unresectable malignant mesothelioma…

Details

Updated ATAGI Advice Regarding AstraZeneca Vaccine

The Australian Government has today received updated advice from the expert vaccine body, the Australian Technical Advisory Group on Immunisation (ATAGI) about the AstraZeneca COVID-19 vaccine.   The experts at ATAGI have today updated their advice to recommend the Pfizer vaccine be preferred for adults aged 59 and under.   The Government fully accepts the…

Details

Local Upgrades Continue Thanks to Roads to Recovery

Local road maintenance in the Mornington Peninsula will receive a welcomed boost thanks to funding under the Morrison Government’s Roads to Recovery Program.   Federal Member for Flinders the Hon Greg Hunt MP said the Australian Government will deliver over $186.5 million to 366 local government authorities nationwide for safer and better-maintained roads.   “Roads across…

Details